Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsConsultation-liaison psychiatry

Psych · Consultation-liaison psychiatry

Stroke and post-stroke psychiatry

Also known as Post-stroke depression · PSD · Poststroke depression · Stroke neuropsychiatry · Vascular depression after stroke · Post-stroke apathy

Fellowship topic on post-stroke depression and psychosis: frequency, predictors and outcomes, the lesion-location question, screening, treatment and prevention trials, and the fluoxetine functional-recovery trials. FRANZCP-primary, globally tagged.

high19 referencesUpdated 26 July 20266 min readSource-verified · Oct 2026

Checked against its sources on 23 Oct 2026

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Individuals with post-stroke depression are at higher risk of suboptimal recovery, recurrent vascular events, poor quality of life and mortality
  • Fluoxetine 20 mg daily for 6 months after acute stroke increased falls, bone fractures and epileptic seizures in AFFINITY
  • SSRIs have been associated with an increased risk of bleeding complications
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Individuals with post-stroke depression are at higher risk of suboptimal recovery, recurrent vascular events, poor quality of life and mortality
  • Fluoxetine 20 mg daily for 6 months after acute stroke increased falls, bone fractures and epileptic seizures in AFFINITY
  • SSRIs have been associated with an increased risk of bleeding complications
The one-line answer

Post-stroke depression affects approximately one third of stroke survivors at any one time after stroke, and carries a higher risk of suboptimal recovery, recurrent vascular events, poor quality of life and mortality.[1] Three large randomised placebo-controlled trials found that fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome.[14][15][16]

Meet the patient

A 68-year-old former teacher, ten days out from a right middle cerebral artery infarct, will not engage with physiotherapy. The nurses have written "low mood, refusing care." Her son says she cried through breakfast, has not slept since admission, and told him the family "would manage better" without her.

Why the examiner cares. Despite validated screening tools and effective treatment and prevention strategies, there has been no significant reduction in the proportion of people experiencing depression after stroke.[2] Only a minority of patients with post-stroke depression are diagnosed, and even fewer are treated in common clinical practice.[18]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References19ShowHide
  1. [1]Towfighi A, Ovbiagele B, El Husseini N, Hackett ML, et al. Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke, 2017.PMID 27932603
  2. [2]Hackett ML, Pickles K Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies Int J Stroke, 2014.PMID 25117911
  3. [3]Kutlubaev MA, Hackett ML Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies Int J Stroke, 2014.PMID 25156411
  4. [4]Ayerbe L, Ayis S, Wolfe CD, Rudd AG Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis Br J Psychiatry, 2013.PMID 23284148
  5. [5]Mitchell AJ, Sheth B, Gill J, Yadegarfar M, et al. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder Gen Hosp Psychiatry, 2017.PMID 28807138
  6. [6]Carson AJ, MacHale S, Allen K, Lawrie SM, et al. Depression after stroke and lesion location: a systematic review Lancet, 2000.PMID 10963248
  7. [7]Robinson RG, Jorge RE Post-Stroke Depression: A Review Am J Psychiatry, 2016.PMID 26684921
  8. [8]Villa RF, Ferrari F, Moretti A Post-stroke depression: Mechanisms and pharmacological treatment Pharmacol Ther, 2018.PMID 29128343
  9. [9]Robinson RG, Jorge RE, Moser DJ, Acion L, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial JAMA, 2008.PMID 18505948
  10. [10]Mikami K, Jorge RE, Moser DJ, Arndt S, et al. Increased frequency of first-episode poststroke depression after discontinuation of escitalopram Stroke, 2011.PMID 21868736
  11. [11]Allida SM, Hsieh CF, Cox KL, Patel K, et al. Pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke Cochrane Database Syst Rev, 2023.PMID 37417452
  12. [12]Allida S, Cox KL, Hsieh CF, House A, et al. Pharmacological, psychological and non-invasive brain stimulation interventions for preventing depression after stroke Cochrane Database Syst Rev, 2020.PMID 32390167
  13. [13]Chollet F, Tardy J, Albucher JF, Thalamas C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial Lancet Neurol, 2011.PMID 21216670
  14. [14]FOCUS Trial Collaboration Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial Lancet, 2019.PMID 30528472
  15. [15]AFFINITY Trial Collaboration Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial Lancet Neurol, 2020.PMID 32702334
  16. [16]EFFECTS Trial Collaboration Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial Lancet Neurol, 2020.PMID 32702335
  17. [17]Stangeland H, Orgeta V, Bell V Poststroke psychosis: a systematic review J Neurol Neurosurg Psychiatry, 2018.PMID 29332009
  18. [18]Paolucci S Epidemiology and treatment of post-stroke depression Neuropsychiatr Dis Treat, 2008.PMID 18728805
  19. [19]Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 2026.PMID 41582814

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSLE and autoimmune neuropsychiatryConsultation-liaison psychiatryNextTraumatic brain injury psychiatryConsultation-liaison psychiatry